Previous studies reported that Cur inhibited cell proliferation correlations with the downregulation of cyclin D1 expression in various cancer types, such as pancreatic, prostate, breast and pituitary tumor cells in both in vitro and in vivo models [25,26,27,28]. This evidence concerns the gene CCND1 and cancer.